🎉 M&A multiples are live!
Check it out!

Kyowa Kirin Co Valuation Multiples

Discover revenue and EBITDA valuation multiples for Kyowa Kirin Co and similar public comparables like Galapagos, Armata Pharmaceuticals, and Pharming.

Kyowa Kirin Co Overview

About Kyowa Kirin Co

Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.


Founded

1949

HQ

Japan
Employees

5.7K+

Website

kyowakirin.com

Financials

LTM Revenue $3.1B

LTM EBITDA $696M

EV

$7.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Kyowa Kirin Co Financials

As of October 2025, Kyowa Kirin Co reported last 12-month revenue of $3.1B and EBITDA of $696M.

In the same period, Kyowa Kirin Co generated $2.3B in LTM gross profit and $360M in net income.

See Kyowa Kirin Co valuation multiples based on analyst estimates

Kyowa Kirin Co P&L

In the most recent fiscal year, Kyowa Kirin Co reported revenue of $3.2B and EBITDA of $739M.

Kyowa Kirin Co expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Kyowa Kirin Co valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $3.1B XXX $3.2B XXX XXX XXX
Gross Profit $2.3B XXX $2.3B XXX XXX XXX
Gross Margin 74% XXX 73% XXX XXX XXX
EBITDA $696M XXX $739M XXX XXX XXX
EBITDA Margin 23% XXX 23% XXX XXX XXX
EBIT $529M XXX $586M XXX XXX XXX
EBIT Margin 17% XXX 19% XXX XXX XXX
Net Profit $360M XXX $382M XXX XXX XXX
Net Margin 12% XXX 12% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Kyowa Kirin Co Stock Performance

Kyowa Kirin Co has current market cap of JPY 1.34T (or $8.6B), and EV of JPY 1.11T (or $7.1B).

Market Cap Evolution

Kyowa Kirin Co Stock Data

As of November 25, 2025, Kyowa Kirin Co's stock price is JPY 2567 (or $16).

See Kyowa Kirin Co trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$7.1B $8.6B XXX XXX XXX XXX $0.68

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Kyowa Kirin Co Valuation Multiples

Kyowa Kirin Co's trades at 2.2x EV/Revenue multiple, and 9.6x EV/EBITDA.

See valuation multiples for Kyowa Kirin Co and 15K+ public comps

Kyowa Kirin Co Financial Valuation Multiples

As of November 25, 2025, Kyowa Kirin Co has market cap of $8.6B and EV of $7.1B.

Equity research analysts estimate Kyowa Kirin Co's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Kyowa Kirin Co has a P/E ratio of 23.8x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $8.6B XXX $8.6B XXX XXX XXX
EV (current) $7.1B XXX $7.1B XXX XXX XXX
EV/Revenue 2.3x XXX 2.2x XXX XXX XXX
EV/EBITDA 10.2x XXX 9.6x XXX XXX XXX
EV/EBIT 13.4x XXX 12.1x XXX XXX XXX
EV/Gross Profit 3.1x XXX n/a XXX XXX XXX
P/E 23.8x XXX 22.4x XXX XXX XXX
EV/FCF -71.8x XXX -29.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Kyowa Kirin Co Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Kyowa Kirin Co Margins & Growth Rates

Kyowa Kirin Co's last 12 month revenue growth is 4%

Kyowa Kirin Co's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.3M for the same period.

Kyowa Kirin Co's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kyowa Kirin Co's rule of X is 33% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Kyowa Kirin Co and other 15K+ public comps

Kyowa Kirin Co Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 4% XXX 1% XXX XXX XXX
EBITDA Margin 23% XXX 23% XXX XXX XXX
EBITDA Growth 9% XXX -5% XXX XXX XXX
Rule of 40 31% XXX 27% XXX XXX XXX
Bessemer Rule of X XXX XXX 33% XXX XXX XXX
Revenue per Employee XXX XXX $0.6M XXX XXX XXX
Opex per Employee XXX XXX $0.3M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 21% XXX XXX XXX
Opex to Revenue XXX XXX 55% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Kyowa Kirin Co Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Kyowa Kirin Co M&A and Investment Activity

Kyowa Kirin Co acquired  XXX companies to date.

Last acquisition by Kyowa Kirin Co was  XXXXXXXX, XXXXX XXXXX XXXXXX . Kyowa Kirin Co acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Kyowa Kirin Co

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Kyowa Kirin Co

When was Kyowa Kirin Co founded? Kyowa Kirin Co was founded in 1949.
Where is Kyowa Kirin Co headquartered? Kyowa Kirin Co is headquartered in Japan.
How many employees does Kyowa Kirin Co have? As of today, Kyowa Kirin Co has 5.7K+ employees.
Who is the CEO of Kyowa Kirin Co? Kyowa Kirin Co's CEO is Mr. Masashi Miyamoto.
Is Kyowa Kirin Co publicy listed? Yes, Kyowa Kirin Co is a public company listed on TKS.
What is the stock symbol of Kyowa Kirin Co? Kyowa Kirin Co trades under 4151 ticker.
When did Kyowa Kirin Co go public? Kyowa Kirin Co went public in 1949.
Who are competitors of Kyowa Kirin Co? Similar companies to Kyowa Kirin Co include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Kyowa Kirin Co? Kyowa Kirin Co's current market cap is $8.6B
What is the current revenue of Kyowa Kirin Co? Kyowa Kirin Co's last 12 months revenue is $3.1B.
What is the current revenue growth of Kyowa Kirin Co? Kyowa Kirin Co revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Kyowa Kirin Co? Current revenue multiple of Kyowa Kirin Co is 2.3x.
Is Kyowa Kirin Co profitable? Yes, Kyowa Kirin Co is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Kyowa Kirin Co? Kyowa Kirin Co's last 12 months EBITDA is $696M.
What is Kyowa Kirin Co's EBITDA margin? Kyowa Kirin Co's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Kyowa Kirin Co? Current EBITDA multiple of Kyowa Kirin Co is 10.2x.
What is the current FCF of Kyowa Kirin Co? Kyowa Kirin Co's last 12 months FCF is -$98.5M.
What is Kyowa Kirin Co's FCF margin? Kyowa Kirin Co's last 12 months FCF margin is -3%.
What is the current EV/FCF multiple of Kyowa Kirin Co? Current FCF multiple of Kyowa Kirin Co is -71.8x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.